The expression of EGFR,PDCD4,TGF-β1,Smad3 and Smad7 during oral buccal mucosa carcinogenesis in chinese hamster
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [26]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    Objective To study the expression and significance of EGFR, PDCD4, TGF-β1, Smad3, Smad7 in oral normal mucosa, oral simple hyperplasia, oral epithelial dysplasia and oral squamous cell carcinomas(OSCC). Methods Serum levels of EGFR, PDCD4 were measeured with ELISA in Chinese hamster during the oral mucosa carcinogenesis; The expressions of TGF-β1, Smad3, Smad7 in oral normal mucosa, oral simple hyperplasia, oral epithelial dysplasia and OSCC tissues were examined by immunohistochemistry. Results In the process of oral carcinogenesis,the expression level of EGFR increased significantly,while the expression of PDCD4 was decreased, the negatively correlation was evident between expression of these two proteins in ED and SCC. The expression of TGF-β1, Smad7 was higher in OSCC than in oral normal mucosa, oral simple hyperplasia, oral epithelial dysplasia(P < 0.05), while the expression of Smad3 was decreased. Further analysis showed the expression of TGF-β1 was correlated with the expression of Smad7. Conclusions The expressions of EGFR, PDCD4, TGF-β1, Smad3, Smad7 are closely related with the biological behaviors of oral squamous cell cancinoma.This experiment provides a theoretical basis for the study of oral squamous cell carcinomas mechanism research. So it has important significance for the development and prognosis of oral squamous carcinomaare.

    Reference
    [1] Kim, E.S, W.K, et al. Chemopreben of aero digestive tract cancers[J]. Annu Rev Med, 2002, 53(9):223-243.
    [2] 邱蔚六.口腔颌面外科学[M].北京:人民卫生出版社. 2010:274.
    [3] 廖汶晓, 闫怡轩, 黄艳青,等.塞来昔布增强口腔癌化疗敏感性与阻滞周期进程的相关性[J]. 南方医科大学学报, 2013, 33(6):885-888.
    [4] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1):11-30.
    [5] Nayyar AS. Novel biochemical markers:early detection and prevention of malignant transformation a pilot study[J]. Acta Med Iran, 2012, 50(9):597-602.
    [6] 姚华,吴葆萱,吴求亮. EGFR在口腔粘膜鳞癌和癌前病变中的表达及意义[J]. 口腔医学, 1999, 19(1):1-3.
    [7] Katz LH, Likhter M, Jogunoori W, et al. TGF-β signaling in liver and gastrointestinal cancers[J]. Cancer Lett, 2016, 379(2):166-172.
    [8] Yokokura S,Kanaji N,Tadokoro A, et al. Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta[J]. Exp Lung Res, 2016, 26(4):175-181.
    [9] Zhu H, Luo H, Shen Z, et al. Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer[J]. Tumour Biol, 2016, 37(6):7075-7083.
    [10] 王海霞, 朱大海. Smad及其结合蛋白在TGFβ信号传导中的功能[J]. 遗传, 2003, 25(4):479-483.
    [11] WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions; an aid to studies on oral precancer[J]. Oral Surg, 1978, 46(4):518-539.
    [12] 钟来平, 郑家伟, 张陈平,等. 口腔癌早期诊断的研究现状[J]. 中国口腔颌面外科杂志, 2007, 5(4):243-247.
    [13] 刘士霞. p53、RAR-β2、Ki-67和EGFR在口腔鳞癌化疗前后的变化及临床意义[J]. 中国临床研究, 2015, 28(7):929-931.
    [14] 刘祥伟,陈德滇, 周绍强. IGF-1、EGFR、Caspase-3在青年女性乳腺癌患者的表达及相关性研究[D]. 昆明医科大学, 2012.
    [15] Chan KK, Glenny AM, Weldon JC, et al. Interventions for the treatment of oral and oropharyngeal cancers:targeted therapy and immunotherapy[J]. Cochrane Database Syst Rev, 2015, (12):CD010341.
    [16] 冯晓宇, 邢汝东,鲁大鹏,等. 口腔颌面部恶性肿瘤患者血清中SCCA、Cyfra21-1、EGFR、CyclinD1含量的检测[J]. 北京口腔医学, 2009, 17(6):309-313.
    [17] 孔海丽, 刘传芳. PDCD4、TGF-β1在急性髓系白血病患者骨髓中的表达及意义[D]. 山东大学, 2011.
    [18] 孙维克, 戚向敏. TGF-β1在口腔扁平苔藓及鳞癌中的表达[J]. 滨州医学院学报,2011,34(6):410-413.
    [19] 蔡传宝, 陶学金, 朱声荣,等. TGF-β1、Smad4和CyclinD1在口腔鳞癌中的表达和意义[J]. 口腔医学研究, 2007, 23(1):14-16.
    [20] 王秀梅, 刘成敏, 张成仁,等. 信号传导通路与肿瘤关系的研究[J]. 现代肿瘤医学, 2009, 17(8):1568-1570.
    [21] Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling[J]. Nature, 2003, 425(6958):577-584.
    [22] Baughn LB,Di Liberto M,Niesvizky R, et al. CDK2 phosphorylation of Smad2 disrupts TGF-beta transcriptional regulation in resistant pri-mary bone marrow myeloma cells[J]. J Immunol, 2009, 182(4):1810-1817.
    [23] Kleeff J, Ishiwata T, Maruyama H, et al. The TGF-β signaling inhibitor Smad7 enhances tumorigencity in pancreatic cancer[J]. Oncogene, 1999, 18(39):5363-5372.
    [24] Huang GW, Mo WN, Kuang GQ, et al. Expression of p16, nm23-HI, E-cadherin and CD44 gene products and their significance in nasopharyngeal carcinoma[J]. Laryngoscope, 2001, 111(8):1465-1471.
    [25] 范晓军, 赵瑞力, 胡俊兰. 喉鳞癌组织中TGF-β1、TβRⅠ、TβRⅡ和Smad7表达及相关研究[D]. 河北医科大学, 2010.
    [26] 马速佳, 周志强, 吴成稳等. 人体胃癌组织中Smad3基因与Smad7基因的相关性表达及其临床意义[J]. 重庆医科大学学报, 2014, 39(3):378-382.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:1956
  • PDF: 2180
  • HTML: 0
  • Cited by: 0
History
  • Received:September 27,2016
  • Online: June 01,2017
Article QR Code